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Objective
Primary cilia regulate intracellular signaling pathways by
sensing the extracellular environment. Abnormalities in
the structure and/or function of cilia results in deregula-
tion of these pathways leading to clinically significant
diseases like cancer. In the present study, we demon-
strate the use of cancer cells in the development of a
cell culture-based semi-high throughput screening
method to identify ciliogenic compounds that may serve
as potential anti-cancer agents. Using this method, we
have identified compounds that enhance ciliation in
pancreatic cancer cells.
Methods
A screening platform was developed by culturing cancer
cells in a 96-well plates followed by immunostaining for
cilia. Quantification of cilia was accomplished by analyz-
ing images captured by INCell Analyzer, an automated
machine used for image acquisition. Ciliogenic com-
pounds were identified based on percentage of ciliated
cells. The hits were further assessed in cancer cells.
Their ability to decrease the proliferation of cancer cells
was analyzed by spheroid assay. Western Blots were per-
formed to identify the pathways through which ciliogen-
esis was induced by these compounds.
Results
26 such compounds were identified which enhanced
ciliation in pancreatic cancer cells. Based on their tar-
gets, they were classified into 14 different classes. Most
of these compounds effectively decreased the rate of
proliferation in pancreatic cancer cells. Two of these
compounds namely Gefitinib and Rapamycin suppressed
the expression levels of transcription factor SREBP1c,
which is known to be overexpressed in cancer cells.
Conclusion
Via development of a semi-high throughput screening
platform, 26 ciliogenic compounds were identified which
may serve as anti-cancer agents by virtue of their ability
to induce cilia in cancer cells.
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